Also trades as: NXGLW (NASDAQ) · $vol 0M
NXGL NASDAQ
NEXGEL, Inc.
1W: +5.8%
1M: -4.4%
3M: -52.0%
YTD: -66.1%
1Y: -74.5%
3Y: -60.6%
$0.56
-0.06 (-9.59%)
Weekly Expected Move ±13.5%
$0
$0
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$5.6M
52W Range0.481-2.89
Volume577,287
Avg Volume388,408
Beta0.74
Dividend—
Analyst Ratings
Company Info
CEOAdam R. Levy
Employees19
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-12-22
Websitenexgel.com
2150 Cabot Boulevard West
Langhorne, PA 19047
US
Langhorne, PA 19047
US
215 702 8550
About NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Latest News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Nexgel (NXGL) Q1 2026 Earnings Transcript
12 Health Care Stocks Moving In Wednesday's After-Market Session
NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition
12 Health Care Stocks Moving In Tuesday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Henry Scott Robert | P-Purchase | 41,667 | $0.60 | 2026-05-14 |
| Henry Scott Robert | P-Purchase | 20,834 | $0.80 | 2026-05-14 |
| Levy Adam R. | P-Purchase | 100,000 | $0.60 | 2026-05-14 |
| Levy Adam R. | P-Purchase | 50,000 | $0.80 | 2026-05-14 |
| Kieser Brian Joseph | P-Purchase | 1,666,667 | $0.60 | 2026-05-11 |